Image de couverture de livre

Understanding the SGLT2 Receptor and its Related Genetics (SLC5A2 Gene): Identifying a Unique Phenotype and Necessary Therapeutic Intervention — A Hypothesis

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mishra, Aditya
Format:	Recurso digital
Publié:	Zenodo 2026
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Repaglinide Revisited: A Temporal Insulin Alignment Hypothesis for β-Cell Preservation and Metabolic Efficiency in Type 2 Diabetes Mellitus
par: Mishra, Aditya
Publié: (2026)

A Multi‐Phenotype Approach to Joint Testing of Main Genetic and Gene‐Environment Interaction Effects
par: Saurabh Mishra, et autres
Publié: (2025)

SGLT‐2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T‐Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes‐Related Hematological Malignancy
par: Kazuho Morichika, et autres
Publié: (2025)

Disruption of the l ‐ DOPA Receptor Gpr143/OA1 ‐Gene in Mice Creates a Unique Mixed Psychosis‐Like Phenotype
par: Yoshio Goshima, et autres
Publié: (2026)

Estrogen‐Related Receptor Gamma (ERRγ) as Biomarker and Novel Target for Therapeutic Intervention on Cancer: A Review
par: Priyanka Upadhyay, et autres
Publié: (2024)

Mendelian Randomization Identified SLC2A9 as a Novel cis‐eQTL‐Mediated Susceptibility Gene in Suppressing Renal Cancer and Its Related Metabolic Mechanisms
par: Yi Wang, et autres
Publié: (2026)

Identification and Validation of the Ferroptosis‐Related Gene SLC2A1 as a Novel Prognostic Biomarker for Osimertinib Resistance in LUAD
par: Lixia Zhang, et autres
Publié: (2026)

A Necessary and Sufficient Condition for Uniqueness of Euclidean Division
par: Sekhon, Senan
Publié: (2026)

The Importance of Newborn Genetic Screening for Early Identification of GJB2 and SLC26A4 Related Hearing Loss
par: Emily R Wener, et autres
Publié: (2025)

Real‐World Effectiveness of SGLT2 Inhibitors Across Heart Failure Phenotypes: A Meta‐Analysis
par: Mohammed Elmujtba A. E, et autres
Publié: (2026)

Expanding the Phenotype of Syndromic SLC30A9 ‐Associated Disease
par: Naomi E. Wagner, et autres
Publié: (2025)

Pan‐Cancer Analysis and Functional Characterization Identify SLC15A4 as a Novel Prognostic Biomarker and Therapeutic Target
par: Xiaodan Lyu, et autres
Publié: (2026)

A Missense Variant in the IKZF2 Gene Identified in a Genetically Undiagnosed Family With Hearing Loss
par: Teng Zhang, et autres
Publié: (2025)

Birkhoff's Theorem and Uniqueness: A Peek Beyond General Relativity
par: Ghosh, Rajes, et autres
Publié: (2024)

Novel Homozygous Full Gene Deletion of SLC12A5 in a Newborn With Refractory Seizures
par: Lauren M. Wainman, et autres
Publié: (2025)

Improvement of Motor Function in SLC39A8‐Related Ataxia Through Manganese Supplementation: A Therapeutic Insight
par: Denise Maria Meneses Cury Portela, et autres
Publié: (2025)

Comprehensive Investigation of Proteoglycan Gene Expression in Breast Cancer: Discovery of a Unique Proteoglycan Gene Signature Linked to the Malignant Phenotype
par: Simone Buraschi, et autres
Publié: (2025)

Novel Variants in the SLC16A2 Gene Associated With Allan–Herndon–Dudley Syndrome in China
par: Wei Li, et autres
Publié: (2026)

Chronic Diarrhoea in Children: The Role of SLC10A2 Gene in Primary Malabsorption of Biliary Acid
par: Marika Comegna, et autres
Publié: (2026)

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
par: Erin F. Barreto, et autres
Publié: (2026)

Genotype and Clinical Phenotype of Monocarboxylate Transporter 1 Deficiency in Three Palestinian Children: Report of Two Novel Variants in the SLC16A1 Gene
par: Imad Dweikat, et autres
Publié: (2025)

Association in Facial Phenotype, Gene, Disease: A Dataset for Explainable Rare Genetic Diseases Diagnosis
par: Song, Jie, et autres
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
par: Mamoor, Shahan
Publié: (2025)

A Unique Case of MBD5 and CCM2 Deletions Leading to a Severe Neurological Phenotype With Prolonged Status Epilepticus
par: Sebastián Silva, et autres
Publié: (2025)

Clinical and Genetic Landscape of IGHMBP2‐Related Disorders: From Novel Variants to Phenotypic Insights
par: Tinatin Tkemaladze, et autres
Publié: (2025)

Gonadal Development–Related Genes and a Male‐Specific Genetic Marker Identified in the Endangered Sichuan Taimen ( Hucho bleekeri )
par: Qinyao Wei, et autres
Publié: (2026)

Phenotypic Characterization of Recently Identified PSEN1 Genetic Variants in ADAD in Colombia
par: Alejandro Guerrero, et autres
Publié: (2025)

Exonic Deletions and Deep Intronic Variants of the SLC26A4 Gene Contribute to the Genetic Diagnosis of Unsolved Patients With Enlarged Vestibular Aqueduct
par: Yongan Tian, et autres
Publié: (2024)

Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP‐ALL cell survival and a potential therapeutic target
par: Giuseppe Taurino, et autres
Publié: (2024)

Identifying Provider Prescribing Practices for GLP‐1RAs and SGLT‐2is in Patients With Type 2 Diabetes to Address Pharmacoinequity
par: Parnnate Wongsirisakul, et autres
Publié: (2026)

Letter to the Editor: Interpreting the Clinical Applicability of SGLT ‐2 Inhibitors in MASH ‐Related Cirrhosis
par: Binqi Wang, et autres
Publié: (2026)

Dormant Metastases Exhibit a Unique Phenotype Primarily Promoted by the Ch25h Gene and Are Maintained in Dormancy by T Lymphocytes
par: Virginia Chamorro, et autres
Publié: (2025)

Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus
Publié: (2024)

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP ‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes
par: Yazan Alhamdan, et autres
Publié: (2026)

SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
par: Fatima Ayub, et autres
Publié: (2025)

Coagulation Dysfunction Caused by a De Novo Mutation of Gene SLC37A4
par: Mauro Guariento, et autres
Publié: (2024)

Identifying Susceptibility Genes and Shared Genetic Architecture for Longevity and Muscle Weakness
par: Yilong Lin, et autres
Publié: (2026)

Ocular Complications of SGLT ‐2 Inhibitors, GLP ‐1 Receptor Agonists, and DPP ‐4 Inhibitors in T2DM Treatments: A Retrospective Real‐World Cohort Study
par: Lee‐Yuan Lin, et autres
Publié: (2025)

Mixed‐Phenotype Acute Leukemia With Mutated TP53 : Genetic Landscape, Therapeutic Response, and Outcomes
par: Wei J. Wang, et autres
Publié: (2025)

Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
par: Aya M. AbdelMagid, et autres
Publié: (2026)